MAP3K14 and chronic kidney disease: The comparison between patients in CKD stages 3, 4, and 5 showed a significant difference in eGFR, proteinuria level, haemoglobin level, hs-CRP, retinal vessel tortuosity, and CRVE results, as well as the use of ACE-I and ARBs between the groups.